Immix Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMMX and other ETFs, options, and stocks.About IMMX
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
IMMX Key Statistics
Stock Snapshot
The current Immix Biopharma(IMMX) stock price is $10.34, with a market capitalization of 736.1M. The stock trades at a price-to-earnings (P/E) ratio of -11.24.
As of 2026-07-04, Immix Biopharma(IMMX) stock has fluctuated between $9.74 and $10.46. The current price stands at $10.34, placing the stock +6.2% above today's low and -1.1% off the high.
The Immix Biopharma(IMMX)'s current trading volume is 2.07M, compared to an average daily volume of 2.92M.
In the last year, Immix Biopharma(IMMX) shares hit a 52-week high of $11.61 and a 52-week low of $1.94.
In the last year, Immix Biopharma(IMMX) shares hit a 52-week high of $11.61 and a 52-week low of $1.94.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.